Stark U, Stark G, Schwarzl I, Poppe H, Marx D, Decrinis M, Tritthart H A
Department of Internal Medicine, Karl-Franzens-University, Graz, Austria.
Cardiovasc Drugs Ther. 1996 Nov;10(5):531-8. doi: 10.1007/BF00050993.
In isolated spontaneously beating guinea pig hearts, the effects of AWD 23-111 (N-(dicyclohexylcarbamoylmethyl)-N-(3-diethylamino-propyl)-4-nit robenzamid -hydrochloride), a new synthetic class III antiarrhythmic agent with sodium antagonistic properties, were investigated on cardiac electrophysiological parameters, that is, conduction and refractoriness. Concentration-dependent prolongation of the atrioventricular, intraventricular, and His bundle conduction times and of sinus node cycle length were present. At 0.3 microM the repolarization period was prolonged significantly. No reverse use-dependent effect on the repolarization period was observed. During rapid pacing (pacing cycle length = 120 ms for the ventricle and 180 ms for the atrium) the rate-dependent intraventricular (QRS) or atrioventricular conduction time (AVCT) prolongation follows an exponential function of the beat number and is characterized by a drug-specific time constant. The time constant for the intraventricular conduction time prolongation in the presence of 0.1 microM AWD 23-111 was very long at 150 +/- 29 beats (mean +/- SEM; n = 6), indicating a slow binding kinetic to the sodium channel. At 0.1 microM AWD 23-111, a significant increase in the ventricular effective refractory period was reached when the interstimulus interval (S1-S1) was 120 ms and the number of conditioning stimuli (S1) was higher than the time constant. The time constant for the rate-dependent AVCT prolongation in the presence of 0.3 microM AWD 23-111 was 34 +/- 6 beats (n = 6). The effective refractory period of the atrioventricular conduction significantly increased with the number of conditioning stimuli (S1), until the number was comparable with the time constant. In conclusion, AWD 23-111 exerts a wide variety of actions on the cardiac conduction system. Its combined effects on the potassium and sodium channels seem to be responsible for the marked rate-dependent effect on ventricular refractoriness and for the lack of a reverse use-dependency on JT prolongation.
在离体自发搏动的豚鼠心脏中,研究了新型具有钠拮抗特性的Ⅲ类抗心律失常药物AWD 23 - 111(N -(二环己基氨基甲酰甲基)- N -(3 - 二乙氨基丙基)- 4 - 硝基苯甲酰胺盐酸盐)对心脏电生理参数,即传导和不应期的影响。存在浓度依赖性地延长房室、心室内和希氏束传导时间以及窦房结周期长度的情况。在0.3微摩尔时,复极期显著延长。未观察到对复极期的反向频率依赖性效应。在快速起搏期间(心室起搏周期长度 = 120毫秒,心房起搏周期长度 = 180毫秒),频率依赖性的心室内(QRS)或房室传导时间(AVCT)延长遵循搏动次数的指数函数,并具有药物特异性的时间常数。在存在0.1微摩尔AWD 23 - 111的情况下,心室内传导时间延长的时间常数在150±29次搏动时非常长(平均值±标准误;n = 6),表明与钠通道的结合动力学缓慢。在0.1微摩尔AWD 23 - 111时,当刺激间期(S1 - S1)为120毫秒且 Conditioning刺激(S1)的数量高于时间常数时,心室有效不应期显著增加。在存在0.3微摩尔AWD 23 - 111的情况下,频率依赖性AVCT延长的时间常数为34±6次搏动(n = 6)。房室传导的有效不应期随Conditioning刺激(S1)的数量显著增加,直至该数量与时间常数相当。总之,AWD 23 - 111对心脏传导系统有多种作用。其对钾通道和钠通道的联合作用似乎是对心室不应期显著的频率依赖性效应以及对JT延长缺乏反向频率依赖性的原因。